ACUPHARMA ApS: Financial statements 2022
CVR: 10072956
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 778,365 and a net result of DKK -449,629 compared with DKK 6,046 the year before. That is a decrease of 34.3% compared with the year before. Equity in the 2022 report amounted to DKK -291,353. The company had 2 employees in the financial year.
- Gross Profit
- DKK 778,365
- Profit/Loss
- DKK -449,629
- Equity
- DKK -291,353
- Total Assets
- DKK 2,010,882
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 778 t. | -450 t. | -291 t. | 2 |
| 2021 | - | 1.2 mio. | 6 t. | 158 t. | 3 |
| 2020 | - | 1.4 mio. | -235 t. | 152 t. | 3 |
| 2019 | - | 1.7 mio. | 33 t. | 387 t. | 4 |
| 2018 | - | 1.7 mio. | 5 t. | 154 t. | - |
Keep an eye on ACUPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ACUPHARMA ApS has published its annual report for 2021. Gross profit came to DKK 1,184,849, and the net result was DKK 6,046.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.